Selectivity

Pre-Clinical Selective Androgen Receptor Modulators (SARMs) are experimental drugs that aim to selectively target androgen receptors in tissues like muscles and bones. These compounds offer potential benefits similar to anabolic steroids but with fewer side effects. Pre-clinical testing is vital for evaluating their efficacy and safety in animal models, helping to understand their mechanisms and identify candidates for clinical trials. Potential uses include treating muscle wasting and osteoporosis, though concerns about long-term safety and misuse in sports remain. Ongoing research strives to enhance benefits while minimizing risks.